| 42.02 |  +0.37 / +0.89%Today’s Change | 40.00 Today|||52-Week Range 45.62 | -3.20% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $103.7B |
Company Description
Sanofi engages in the research, production and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Human Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes & cardiovascular, established prescription products and generics, together with research, development and production activities. This segment also includes all associates whose activities are related to pharmaceuticals. The Consumer Healthcare segment comprises, for all geographical territories, the commercial operations for its Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development and production activities dedicated to vaccines. The company was founded in 1973 and is headquartered in Paris, France.
Employees
Shareholders
| Other institutional | 3.54% |
| Mutual fund holders | 3.47% |
| Individual stakeholders | -- |
Top Executives
| Olivier Brandicourt | Chief Executive Officer & Director |
| Jean-Baptiste Chasseloup de Chatillon | Chief Financial Officer & Executive Vice President |
| Ameet Nathwani | Chief Medical & Digital Officer |
| Nestle Frank | Global Head-Immunology Therapeutic Research Area |
| John C. Reed | Head-Global Research & Development |
+0.37 / +0.89%
